Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders

H. Y. Chin, K. C. Lin, C. H. Chiang, C. J. Wang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purposte of study: To evaluate the efficacy of baclofen in combination with antimuscarinics to treat women with an overactive bladder (OAB) with abnormal voiding patterns. Methods: An action research and chart review was conducted in 245 OAB women. Women were prescribed tolterodine or oxybutynin with or without baclofen after urodynamics. The complaint of voiding difficulty was followed up one week later. Results: There was a significant difference in the occurrence of voiding difficulty after antimuscarinic administration in OAB women with abnormal voiding patterns compared with normal patterns (18% vs 4.9%, respectively; p = 0.013). The clinical difference of voiding difficulty after treating with antimuscarinics between both voiding patterns disappeared after adding baclofen (abnormal voiding pattern vs normal pattern; 11.1% vs 5.6%, respectively; p = 1.000). Conclusion: Combined use of baclofen and antimuscarinic agents could reduce voiding difficulty in treating women with overactive bladders with abnormal voiding patterns.

Original languageEnglish
Pages (from-to)171-174
Number of pages4
JournalClinical and Experimental Obstetrics and Gynecology
Volume39
Issue number2
Publication statusPublished - Jul 13 2012
Externally publishedYes

Fingerprint

Overactive Urinary Bladder
Baclofen
Muscarinic Antagonists
Urodynamics
Health Services Research

Keywords

  • Antimuscarinics
  • Baclofen
  • Overactive bladder
  • Urodynamics
  • Voiding pattern

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders. / Chin, H. Y.; Lin, K. C.; Chiang, C. H.; Wang, C. J.

In: Clinical and Experimental Obstetrics and Gynecology, Vol. 39, No. 2, 13.07.2012, p. 171-174.

Research output: Contribution to journalArticle

@article{4e8ec2ebd27e4eeb88d76bcfd9b3dd9a,
title = "Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders",
abstract = "Purposte of study: To evaluate the efficacy of baclofen in combination with antimuscarinics to treat women with an overactive bladder (OAB) with abnormal voiding patterns. Methods: An action research and chart review was conducted in 245 OAB women. Women were prescribed tolterodine or oxybutynin with or without baclofen after urodynamics. The complaint of voiding difficulty was followed up one week later. Results: There was a significant difference in the occurrence of voiding difficulty after antimuscarinic administration in OAB women with abnormal voiding patterns compared with normal patterns (18{\%} vs 4.9{\%}, respectively; p = 0.013). The clinical difference of voiding difficulty after treating with antimuscarinics between both voiding patterns disappeared after adding baclofen (abnormal voiding pattern vs normal pattern; 11.1{\%} vs 5.6{\%}, respectively; p = 1.000). Conclusion: Combined use of baclofen and antimuscarinic agents could reduce voiding difficulty in treating women with overactive bladders with abnormal voiding patterns.",
keywords = "Antimuscarinics, Baclofen, Overactive bladder, Urodynamics, Voiding pattern, Antimuscarinics, Baclofen, Overactive bladder, Urodynamics, Voiding pattern",
author = "Chin, {H. Y.} and Lin, {K. C.} and Chiang, {C. H.} and Wang, {C. J.}",
year = "2012",
month = "7",
day = "13",
language = "English",
volume = "39",
pages = "171--174",
journal = "Clinical and Experimental Obstetrics and Gynecology",
issn = "0390-6663",
publisher = "S.O.G. CANADA Inc.",
number = "2",

}

TY - JOUR

T1 - Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders

AU - Chin, H. Y.

AU - Lin, K. C.

AU - Chiang, C. H.

AU - Wang, C. J.

PY - 2012/7/13

Y1 - 2012/7/13

N2 - Purposte of study: To evaluate the efficacy of baclofen in combination with antimuscarinics to treat women with an overactive bladder (OAB) with abnormal voiding patterns. Methods: An action research and chart review was conducted in 245 OAB women. Women were prescribed tolterodine or oxybutynin with or without baclofen after urodynamics. The complaint of voiding difficulty was followed up one week later. Results: There was a significant difference in the occurrence of voiding difficulty after antimuscarinic administration in OAB women with abnormal voiding patterns compared with normal patterns (18% vs 4.9%, respectively; p = 0.013). The clinical difference of voiding difficulty after treating with antimuscarinics between both voiding patterns disappeared after adding baclofen (abnormal voiding pattern vs normal pattern; 11.1% vs 5.6%, respectively; p = 1.000). Conclusion: Combined use of baclofen and antimuscarinic agents could reduce voiding difficulty in treating women with overactive bladders with abnormal voiding patterns.

AB - Purposte of study: To evaluate the efficacy of baclofen in combination with antimuscarinics to treat women with an overactive bladder (OAB) with abnormal voiding patterns. Methods: An action research and chart review was conducted in 245 OAB women. Women were prescribed tolterodine or oxybutynin with or without baclofen after urodynamics. The complaint of voiding difficulty was followed up one week later. Results: There was a significant difference in the occurrence of voiding difficulty after antimuscarinic administration in OAB women with abnormal voiding patterns compared with normal patterns (18% vs 4.9%, respectively; p = 0.013). The clinical difference of voiding difficulty after treating with antimuscarinics between both voiding patterns disappeared after adding baclofen (abnormal voiding pattern vs normal pattern; 11.1% vs 5.6%, respectively; p = 1.000). Conclusion: Combined use of baclofen and antimuscarinic agents could reduce voiding difficulty in treating women with overactive bladders with abnormal voiding patterns.

KW - Antimuscarinics

KW - Baclofen

KW - Overactive bladder

KW - Urodynamics

KW - Voiding pattern

KW - Antimuscarinics

KW - Baclofen

KW - Overactive bladder

KW - Urodynamics

KW - Voiding pattern

UR - http://www.scopus.com/inward/record.url?scp=84863613335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863613335&partnerID=8YFLogxK

M3 - Article

C2 - 22905457

AN - SCOPUS:84863613335

VL - 39

SP - 171

EP - 174

JO - Clinical and Experimental Obstetrics and Gynecology

JF - Clinical and Experimental Obstetrics and Gynecology

SN - 0390-6663

IS - 2

ER -